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Abstract Circular dichroism, and steady-state and time-
resolved fluorescence spectroscopy were used to compare the 
native recombinant human DNA repair protein C^-alkylguanine-
DNA alkyltransferase (AGT) with AGT bound to ds-DNA. 
Contrary to fluorescence, analysis of the far-UV CD spectra 
indicated a conformational change of AGT upon binding to 
DNA: its a-helical content is increased by ~ 1 2 % . Analysis of 
near-UV CD spectra revealed that DNA was also affected, 
probably being separated into single strands locally. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
The D N A repair protein 0 6 -a lkylguanine-DNA alkyltrans-
ferase ( A G T ; EC 2.1.1.63) removes covalently bound alkyl 
groups from the mutagenic and toxic D N A lesion 06-alkyl-
guanine (O e-AlkGua) by a stoichiometric one-step 'suicide' 
reaction (for review see [1,2]). Apparently, A G T is active in 
the absence of other proteins or cofactors [3,4]. Binding of 
A G T to D N A , a prerequisite for D N A repair, is non-specific 
and mediated mainly by ionic interactions [4]. 
The crystal structure of a 19 k D a C-terminal fragment of 
bacterial A G T (Ada) was published by Moore et al. [5]. This 
fragment contains the active center and is homologous to 
human A G T . The active site thiol of Cysu®C, corresponding 
to Cysi21 in the full-length Ada protein, is buried [5]. A con-
formational change is, therefore, required to activate A G T . 
Simple swiveling of the C-terminal helix (165C-175C) about 
the loop residues 150C-160C would expose a potential D N A 
binding surface and simultaneously render the thiol of 
Cy.s146C accessible to duplex D N A [5]. Analysis of the pro-
te in-DNA complex by circular dichroism (CD) and steady-
state fluorescence suggests that the interaction of human 
A G T with D N A induces a conformational change in the pro-
tein [6]. The question remains whether binding of A G T to 
D N A also induces a conformational change in D N A ; e.g. it 
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has been suggested that A G T rotates the target alkylnucleo-
tide out of the D N A double helix [7]. 
C D is highly sensitive to restrained dynamics and asymme-
try in the environment of optically active chromophores (near-
UV), and represents a measure for the secondary structure of 
proteins (far-UV [8]) and D N A (near-UV [9,10]). The decay 
of Trp fluorescence intensity reflects the local environment of 
Trp residues. Decay of fluorescence anisotropy provides inde-
pendent information on changes of protein shape and on Trp 
side-chain dynamics. 
We have investigated the interaction of recombinant human 
A G T with native ds -DNA, using C D and time-resolved fluo-
rescence spectroscopy. 
2. Materials and methods 
Native recombinant human AGT was prepared by a combination 
of Ni2+-nitrilo-triacetic acid (NTA)-agarose affinity chromatography 
and ion exchange chromatography, as described previously [4]. 
2.1. Fluorescence spectroscopy 
For fluorescence measurements the same solutions were used as for 
CD. Optical density was <0.1 (0.4 cm pathlength) at the wavelength 
used for excitation. 
Steady-state fluorescence spectra were recorded on a Spex Fluoro-
log 211 photon counting spectrofluorimeter (Spex Industries, New 
York, USA [11]). 
2.2. Time-resolved fluorescence spectroscopy 
Fluorescence lifetimes and fluorescence anisotropy decays (FAD) 
were measured in the single photon counting mode, using a model 
199 Edinburgh Instruments Ltd. Spectrometer (Edinburgh, UK), as 
outlined previously [11,12]. 
2.3. CD 
Prior to measurements AGT was transferred to 20 mM NaH2PCV 
Na 2HP0 4 , pH 7.6; 50 mM NaF; 10% glycerol; 50 uM EDTA; 1 mM 
ß-mercaptoethanol, by gel exclusion chromatography (PD-10, Phar-
macia-LKB). NaCl was replaced by NaF for better transparency in 
the far-UV. High molecular weight calf thymus DNA (Boehringer 
Mannheim, Mannheim, Germany) was dialyzed against 20 mM 
NaH2P04/Na2HP04, pH 7.6; 10% glycerol; 50 uM EDTA overnight. 
Protein and DNA concentrations were determined spectrophotometri-
cally (PU 8800, Philips), using E[280] = 28.900 [M"1 cm H ] for AGT 
[11] and e[260] = 20.0 [1/g-cm] for DNA. 
CD measurements were carried out on an AVIV 62DS CD spec-
trometer (Lakewood, NJ, USA) and a Jasco J-600 spectropolarimeter 
(Japan Spectroscopic Co. Ltd., Tokyo, Japan), both calibrated with a 
0.1% aqueous solution of d-10-camphorsulfonic acid [13]. The spectral 
bandwidth was 1.5 nm. In order to prevent artefacts varying the 
pathlength of the cell (0.01-10 mm) limited the absorption of the 
sample and, thus, the voltage of the photomultiplier. To determine 
secondary structural composition, spectra were analyzed with the 
CONTIN program package [14]. Further details have previously 
been described [15]. 
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Table 1 
Fluorescence lifetime (A) and anisotropy decay data (B) 
A 
AGTa 
AGT, DNAb 
B 
AGTa 
AGT, DNAb 
Bi 
0.07 
0.08 
rQ 
0.166 
0.169 
B2 
0.37 
0.38 
ri 
0.102 
0.072 
B3 
0.56 
0.54 
r« 
0.064 
0.097 
Ti [ns] 
0.76 
0.79 
0 [ns] 
13.6 
15.1 
T2 [ns] 
3.21 
3.23 
X2 
0.72 
1.16 
x3 [ns] 
8.24 
8.35 
x2 
1.18 
1.18 
< x > [ns] 
5.9 
5.8 
Excitation wavelength, 295 nm; bandwidth, 12 nm. The fluorescence emission was passed through filters DUG 11 and WG 320. At least 80000 
counts were accumulated in the peak channel of the total fluorescence intensity. The lamp pulse was recorded at 345 nm using a diluted suspension 
of 'Ludox' (Du Pont, Wilmington, DE, USA). All measurements were carried out at 4°C. a0.98 g/1 AGT, b1.0 g/1 AGT and 0.15 g/1 calf thymus 
DNA. 
(A) Total fluorescence intensity decays were fitted to the equation s(t) = b0+Ebjexp(-t/Ti) with 1 = 1, 2,...n. bi and T; are the amplitude and lifetime of 
the ith excited state, respectively; x2, reduced chi-squared. Bi, and the mean lifetime, <%>, were calculated according to: < x > = IBjTi = Zfbjtj/ 
(B) Anisotropy decays were fitted to r(t) = riexp(—t/o)+rœ; A, anisotropies; 0, the rotational correlation time. The limiting anisotropies are: 
r(t->0) = ro, and r(t-> oo) = rœ, r0 = r1+r„. 
3. Results and discussion 
3.1. Steady-state fluorescence 
The fluorescence emission spectra of native and DNA-
bound AGT peaked at ^.= 342.5 nm, with a full width at 
half maximum (FWHM) of 58.5 nm. Hence, the fluorescence 
emission properties of the Trp residues do not reflect DNA 
binding nor the conformational changes induced in AGT 
upon binding (see below). This may be explained by Trp65 
being located in the N-terminal domain which is probably 
not involved in DNA binding [5]. Trp100 is not essential for 
DNA binding [16]. Trp167 is part of the C-terminal helix which 
has been proposed to fit into the major groove of DNA me-
diating the binding to DNA [5]. Trplm should, therefore, be a 
good reporter group. Unfortunately its fluorescence signal 
appears to be quenched by the neighboring Glu166 [17,18]. 
Removal of 31 C-terminal amino acids from human AGT 
does not affect its repair activity [19]. Trp191 is, therefore, 
not involved in DNA binding. The proposed elongation of 
the helices (see below) would not affect any of the Trp resi-
dues. 
3.2. Time-resolved fluorescence spectroscopy 
The results of time-resolved fluorescence measurements are 
presented in Table 1. In parallel to the steady-state data the 
mean fluorescence lifetime, < x > , of AGT was not signifi-
cantly changed upon addition of DNA. Binding of AGT to 
DNA was only reflected by an increase of the limiting aniso-
tropy, rœ, because - compared to < x > of Trp residues - the 
AGT-DNA complex has a much longer rotational correlation 
time, 0. Assuming that the residual r» is only due to the 
mismatch of < x > and 0 in the case of pure AGT [11], the 
fraction of AGT bound to DNA can be estimated from the 
ratio of roo/r0 = 0.097/0.169 to be ~ 5 7 % (Table IB). This val-
ue is in reasonable agreement with the prediction based on the 
law of mass action (equation (1) in [11]). The respective values 
from Fig. 1 (47.5 uM AGT; and 231 uM base pairs=23.1 uM 
binding sites, association constant 7.1 XlO5 M _ 1 [4]) resulted 
in a concentration of occupied binding sites of 21.9 |iM. 
Hence, almost all of the DNA and ~ 50% of the AGT mol-
ecules were bound. 
3.3. CD spectroscopy 
Upon addition of calf thymus DNA, both the magnitude of 
the far-UV CD signal and the a-helical content were increased 
( ~ 6 % in the case of 0.15 g/1 DNA; Fig. 1A; Table 2). Only a 
limited amount of DNA could be added, beyond which pre-
cipitation started. The turbidity of the solutions was carefully 
examined and all measurements were carried out with clear 
solutions. The spectra were measured at A,>200 nm only, due 
to the high absorption of the DNA. Nevertheless the deter-
mination of the a-helical content is reliable [8]. The secondary 
structural composition of AGT determined here is in reason-
able agreement with the values calculated from the homology 
model of the three-dimensional structure of human AGT 
based on the crystal structure of the C-terminal domain of 
Ada [11]. The CD signal of DNA was subtracted, although 
it was negligible in the far-UV when compared to the AGT 
signal. 
Since only ~ 50% of AGT molecules are bound to DNA, 
the a-helical content is actually increased by ~ 12%, corre-
sponding to 25 amino acids or almost seven turns. The in-
crease in a-helical content is at variance with the data of Chan 
et al. [6] who observed a decrease of ~ 7 % while the content 
of ß-turns was increased by ~ 7%. This discrepancy may per-
haps be attributed to partial precipitation of the protein. Both 
alkylation of AGT and binding to DNA result in similar 
conformational changes of AGT but in the latter case they 
Table 2 
Secondary structural composition of AGT and AGT bound to DNA 
Protein 
(1) AGT 
(2) AGT, 0.073 g/1 DNA 
(3) AGT, 0.15 g/1 DNA 
a-helix 
24.9 
27.7 
31.6 
[%] ß-sheet [%] 
anti-par. 
18.2 
17.2 
15.1 
par. 
5.1 
4.7 
5.2 
ß-turn [%] 
18.1 
17.9 
16.7 
remainder [%] 
33.7 
32.5 
31.4 
Secondary structural composition of AGT was determined from far-UV CD spectra using the CONTEST program [14]. Spectra were measured from 
200 to 245 nm at room temperature. AGT concentrations are given in Fig. 1A. 
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Fig. 1. CD spectra of native human AGT incubated with DNA. 
A: Far-UV; B, C: near-UV. Samples were prepared as described in 
Section 2 and measured at room temperature (25°C). In the case of 
A and B, the spectra of pure calf thymus DNA were subtracted. In 
C, the spectra of the pure protein solution were subtracted. A, 
B: [8]MRW is given in degrees X cm2 Xdecimol-1. C: The spectra are 
normalized to the molar concentration of DNA bases. The spectra 
shown are original tracings including noise. A: (1) 1.02 g/1 AGT; 
(2) 1.02 g/1 AGT, 0.073 g/1 calf thymus DNA; (3) 1.0 g/1 AGT, 0.15 
g/1 DNA. B, C: (1) 1.03 g/1 AGT; (2) 1.02 g/1 AGT, 0.073 g/1 
DNA; (3) 1.03 g/1 AGT, 0.3 g/1 DNA; (4) 0.073 g/1 DNA. 
are more pronounced [11]. Alkylation may 'freeze' some of 
the conformational changes induced by DNA binding (see 
below). 
For the binding of Ada to DNA, Moore et al. [5] proposed 
a generalized binding to DNA mediated by a variant of the 
helix-turn-helix motif comprising the helices three, four and 
five, as well as fitting of the C-terminal helix into the major 
groove of DNA. There is experimental evidence for both, (i) 
In human AGT Arg12S is required in order to interact with the 
DNA substrate [20,21]. Actually the protein conformation in 
the vicinity of Arg128 exhibits close homology to the helix-
hairpin-helix motif [22] (h is a hydrophobic residue) : 
hxxhxGhGxxxAxxhh 
QQLAALAGNPKAARAV 
(codons 115-130 of human AGT, amino acids in accordance 
with the motif are typed in bold, fully conserved residues are 
underlined). This motif provides non-sequence-specific inter-
actions of proteins and DNA and can bind either ss-DNA or 
ds-DNA. Conformational stabilization and elongation of heli-
ces upon binding to DNA are common features of helix-turn-
helix proteins [23]. Hence, upon binding to DNA the loop 
between helices four and five probably becomes almost heli-
cal, and helix four may be extended at its N-terminus. (ii) The 
G156A mutant was stimulated only very slightly by addition 
of DNA [19], indicating the involvement of parts of AGT 
positioned C-terminally of the active site, especially the C-
terminal helix which may be involved in DNA binding similar 
to the 'hinge' helix of the PurR repressor [24]. DNA binding 
may cause helix six to be extended N-terminally because the 
C-terminal the residues are not conserved in different species. 
In favor of two binding sites are also the results of Kanugula 
et al. [20] obtained with the R128A mutant AGT: addition of 
ss-DNA increased the activity of this mutant in cleaving O6-
benzylguanine considerable less than ds-DNA while both ss-
and ds-DNA are effective in causing stimulation in the case of 
native AGT. ss-DNA will occupy only one site in the case of 
R128A which is insufficient to fully stimulate AGT. ds-DNA, 
combining the residual affinity of the R128A site and of the 
other site, binds to both sites and fully stimulates AGT. 
In the near-UV, the CD spectra of pure protein and DNA 
were of similar magnitude. The spectrum of calf thymus DNA 
measured in the present study was very similar to that pub-
lished by Fairall et al. [25]. Spectral changes in the near-UV 
may, in principle, be due to conformational changes either in 
AGT or DNA, or in both molecules. When the undisturbed 
spectrum of DNA is subtracted (Fig. IB), all of the changes 
are attributed to AGT. In this case the magnitude of the near-
UV CD spectrum is increased (Fig. IB), in accordance with 
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the data of Chan et al. [6]. Pure AGT exhibits a relatively 
pronounced near-UV CD spectrum, probably because of its 
rather rigid structure [11]. Therefore, the increase in the signal 
is unlikely to originate exclusively from alterations within the 
AGT molecule, in particular since only ~ 50% of AGT mol-
ecules were bound to DNA. 
Attributing all of the conformational changes to DNA re-
sults in a decreased CD signal at 275 nm while its shape does 
not change (Fig. 1C). As the winding angle of the DNA helix 
increases, the twist angle of the base pairs, and thus the CD 
signal decrease [26]. When DNA is bent, winding angle and 
base-pair twist change in a similar way, also resulting in a 
decreased CD signal [27]. Hence, DNA may be either over-
wound or bent by AGT; or in association with bending the 
DNA may be overwound similar to the situation in some 
protein-DNA complexes involving proteins which contain a 
helix-turn-helix DNA-binding motif [28,29]. Overwinding ob-
structs formation of single-stranded regions. Locally induced 
ss-DNA which has been suggested by Spratt and Campbell 
[30] would also be in accordance with the near-UV CD spec-
tra [31]. Since this would facilitate rotation of the target alkyl-
nucleotide out of the DNA double helix [7], it is the more 
probable conformational change induced by bound AGT. 
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